Browsing by Author Arsenijevic, Nebojsa

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 61 to 80 of 159 < previous   next >
PreviewIssue DateTitleAuthor(s)
10.3389-fmed.2021.749569.pdf.jpg30-Nov-2021IL 33 Correlates With COVID-19 Severity, Radiographic and Clinical FindingMarković, Veronika; Jovanovic M.; Gajovic N.; Jurisevic M.; Arsenijevic, Nebojsa; Jovanovic M.; Jovanovic M.; Mijailovic Z.; Lukić J.; Zornic, Nenad; Vukicevic V.; Stojanović, Biljana J.; Maric V.; Jocic M.; Jovanovic I.
10.2298-VSP180727158P.pdf.jpg1-Jan-2020IL-32 expression associated with lymph vessel invasion in intestinal type of gastric cancerPavlovic, Mladen; Jurisevic M.; Gajovic N.; Mitrović P.; Jovanovic M.; Radosavljevic, Gordana; Pantic, Jelena; Radovanovic D.; Arsenijevic, Nebojsa; Jovanovic I.
10.3389-fimmu.2018.02646.pdf.jpg15-Nov-2018IL-33 prevents MLD-STZ induction of diabetes and attenuate insulitis in prediabetic NOD micePavlovic S.; Petrović, Ivica; Jovicic, Nemanja; Ljujic, Biljana; Miletic Kovacevic, Marina; Arsenijevic, Nebojsa; Lukic, Miodrag
10.1186-s12929-018-0455-z.pdf.jpg12-Jul-2018IL-33 receptor (ST2) deficiency downregulates myeloid precursors, inflammatory NK and dendritic cells in early phase of sepsisBabic Z.; Zunic F.; Pantic, Jelena; Radosavljevic, Gordana; Jovanovic I.; Arsenijevic, Nebojsa; Lukic, Miodrag
PaperMissing.pdf.jpg1-Aug-2019IL-33/IL-33R in various types of carotid artery atherosclerotic lesionsStankovic, Milos; Ljujic, Biljana; Babic Z.; Maravic-Stojkovic V.; Mitrović I.; Arsenijevic, Nebojsa; Radak D.; Pejnović, Nada; Lukic, Miodrag
PaperMissing.pdf.jpg1-Apr-2012IL-33/ST2 axis in inflammation and immunopathologyMilovanovic, Marija; Volarevic, Vladislav; Radosavljevic, Gordana; Jovanovic I.; Pejnović, Nada; Arsenijevic, Nebojsa; Lukic, Miodrag
10.4161-onci.1.2.18131.pdf.jpg29-Oct-2012IL-33/ST2 axis in innate and acquired immunity to tumorsJovanovic I.; Pejnović, Nada; Radosavljevic, Gordana; Arsenijevic, Nebojsa; Lukic, Miodrag
PaperMissing.pdf.jpg1-Aug-2017In vitro and in vivo anti-tumor effects of selected platinum(IV) and dinuclear platinum(II) complexes against lung cancer cellsArsenijević, Momir; Milovanovic, Marija; Jovanovic I.; Arsenijevic, Nebojsa; Simovic Markovic, Bojana; Gazdic, Marina; Volarevic, Vladislav
PaperMissing.pdf.jpg1-Dec-2021In vitro and in vivoactivity of series of cationic dinuclearPt(II) complexesVasić I.; Rajković, Snežana; Arsenijevic A.; Milovanovic, Marija; Arsenijevic, Nebojsa; Milovanovic, Jelena; Zivkovic, Marija
PaperMissing.pdf.jpg1-Sep-2015In vivo administration of the frog skin peptide frenatin 2.1S induces immunostimulatory phenotypes of mouse mononuclear cellsPantic, Jelena; Radosavljevic, Gordana; Jovanovic I.; Arsenijevic, Nebojsa; Conlon, John Michael; Lukic, Miodrag
PaperMissing.pdf.jpg1-Jan-2015Increase systemic levels of IL-23 as a possible constitutive marker in schizophreniaBorovcanin, Milica; Jovanovic I.; Dejanovic S.; Radosavljevic, Gordana; Arsenijevic, Nebojsa; Lukic, Miodrag
10.1620-tjem.254.171.pdf.jpg1-Jan-2021Increased severity of ulcerative colitis in the terminal phase of the metabolic syndromeJovanovic M.; Jurisevic M.; Gajovic N.; Arsenijevic, Nebojsa; Jocic M.; Jovanovic I.; Zdravković N.; djukic, aleksandar; Maric V.; Jovanovic M.
10.3855-jidc.11741.pdf.jpg31-May-2020Increased systemic sST2 in patients with end stage renal disease contributes to milder liver damage during HCV infectionLukic R.; Čupić, Milan; Gajovic N.; Jurisevic M.; Mijailovic Z.; Davidovic B.; Kujundžic B.; Joksimović B.; Arsenijevic, Nebojsa; Jovanovic I.
10.1177-1756284818793558.pdf.jpg1-Jan-2018Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitisAcovic A.; Simovic Markovic, Bojana; Gazdic, Marina; Arsenijevic A.; Jovicic, Nemanja; Gajovic N.; Jovanovic M.; Zdravković N.; Kanjevac, Tatjana; Harrell C.; Fellabaum, Crissy; Dolicanin Z.; Djonov V.; Arsenijevic, Nebojsa; Lukic, Miodrag; Volarevic, Vladislav
10.3389-fpsyt.2022.925757.pdf.jpg25-Jul-2022Influence of antipsychotics on metabolic syndrome risk in patients with schizophreniaKorićanac A.; Tomic Lucic, Aleksandra; Veselinović M.; Bazic Sretenovic, Danijela; Bucic G.; Azanjac A.; Radmanovic O.; Matovic, Milovan; Stanojević M.; Jurisic Skevin, Aleksandra; Simovic Markovic, Bojana; Pantic, Jelena; Arsenijevic, Nebojsa; Radosavljevic, Gordana; Nikolic M.; Zornic, Nenad; Nesic, Jelena; Muric, Nemanja; Radmanovic, Branimir
10.1515-SJECR-2015-0011.pdf.jpg1-Jan-2015Innate lymphoid cells: Roles in tumour genesis and progressionJovanovic I.; Gajovic N.; Radosavljevic, Gordana; Pantic, Jelena; Pejnović, Nada; Arsenijevic, Nebojsa; Lukic, Miodrag
PaperMissing.pdf.jpg1-Jun-2010Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesisVolarevic, Vladislav; Al-Qahtani A.; Arsenijevic, Nebojsa; Pajovic B.; Lukic, Miodrag
10.3389-fimmu.2020.00947.pdf.jpg3-Jun-2020Interleukin-17 in Chronic Inflammatory Neurological DiseasesMilovanovic, Jelena; Arsenijevic A.; Stojanovic B.; Kanjevac, Tatjana; Arsenijevic D.; Radosavljevic, Gordana; Milovanovic, Marija; Arsenijevic, Nebojsa
10.4149-neo_2010_02_135.pdf.jpg1-Jan-2010Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinomaRadosavljevic, Gordana; Ljujic, Biljana; Jovanovic I.; Srzentic Z.; Pavlovic G.; Zdravkovic, Nemanja; Milovanovic, Marija; Banković D.; Knezevic M.; Aćimović L.; Arsenijevic, Nebojsa
10.1515-sjecr-2016-0085.pdf.jpg16-Feb-2018Interleukin-32 in Infection, Inflammation and Cancer BiologyPavlovic, Mladen; Jovanovic I.; Arsenijevic, Nebojsa